Your payment is in progress...
  +1 (704) 266-3234

Global Prostate Cancer Diagnostics Market Research Report 2020

Published on: Jan 2020 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 116

The prostate is a walnut-sized gland located behind the base of a manís penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.
The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2017 is about 44.65%.
Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 70.24% in 2017.
North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49.84% in 2017. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28% in 2017.

The global Prostate Cancer Diagnostics market is valued at 11600 million US$ in 2020 is expected to reach 19100 million US$ by the end of 2026, growing at a CAGR of 7.3% during 2021-2026.
This report focuses on Prostate Cancer Diagnostics volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Prostate Cancer Diagnostics market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Prostate Cancer Diagnostics market is segmented into
Tumor Biomarker Tests
Imaging
Biopsy
Other

Segment by Application
age < 55
age 55-75
age > 75

Global Prostate Cancer Diagnostics Market: Regional Analysis
The Prostate Cancer Diagnostics market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Prostate Cancer Diagnostics market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Prostate Cancer Diagnostics Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Prostate Cancer Diagnostics market include:
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
BioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics

Table of Contents

1 Prostate Cancer Diagnostics Market Overview
1.1 Product Overview and Scope of Prostate Cancer Diagnostics
1.2 Prostate Cancer Diagnostics Segment by Type
1.2.1 Global Prostate Cancer Diagnostics Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Tumor Biomarker Tests
1.2.3 Imaging
1.2.4 Biopsy
1.2.5 Other
1.3 Prostate Cancer Diagnostics Segment by Application
1.3.1 Prostate Cancer Diagnostics Sales Comparison by Application: 2020 VS 2026
1.3.2 age < 55
1.3.3 age 55-75
1.3.4 age > 75
1.4 Global Prostate Cancer Diagnostics Market Size Estimates and Forecasts
1.4.1 Global Prostate Cancer Diagnostics Revenue 2015-2026
1.4.2 Global Prostate Cancer Diagnostics Sales 2015-2026
1.4.3 Prostate Cancer Diagnostics Market Size by Region: 2020 Versus 2026

2 Global Prostate Cancer Diagnostics Market Competition by Manufacturers
2.1 Global Prostate Cancer Diagnostics Sales Market Share by Manufacturers (2015-2020)
2.2 Global Prostate Cancer Diagnostics Revenue Share by Manufacturers (2015-2020)
2.3 Global Prostate Cancer Diagnostics Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Prostate Cancer Diagnostics Manufacturing Sites, Area Served, Product Type
2.5 Prostate Cancer Diagnostics Market Competitive Situation and Trends
2.5.1 Prostate Cancer Diagnostics Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Prostate Cancer Diagnostics Players (Opinion Leaders)

3 Prostate Cancer Diagnostics Retrospective Market Scenario by Region
3.1 Global Prostate Cancer Diagnostics Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Prostate Cancer Diagnostics Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Prostate Cancer Diagnostics Market Facts & Figures by Country
3.3.1 North America Prostate Cancer Diagnostics Sales by Country
3.3.2 North America Prostate Cancer Diagnostics Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prostate Cancer Diagnostics Market Facts & Figures by Country
3.4.1 Europe Prostate Cancer Diagnostics Sales by Country
3.4.2 Europe Prostate Cancer Diagnostics Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prostate Cancer Diagnostics Market Facts & Figures by Region
3.5.1 Asia Pacific Prostate Cancer Diagnostics Sales by Region
3.5.2 Asia Pacific Prostate Cancer Diagnostics Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Prostate Cancer Diagnostics Market Facts & Figures by Country
3.6.1 Latin America Prostate Cancer Diagnostics Sales by Country
3.6.2 Latin America Prostate Cancer Diagnostics Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Prostate Cancer Diagnostics Market Facts & Figures by Country
3.7.1 Middle East and Africa Prostate Cancer Diagnostics Sales by Country
3.7.2 Middle East and Africa Prostate Cancer Diagnostics Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Prostate Cancer Diagnostics Historic Market Analysis by Type
4.1 Global Prostate Cancer Diagnostics Sales Market Share by Type (2015-2020)
4.2 Global Prostate Cancer Diagnostics Revenue Market Share by Type (2015-2020)
4.3 Global Prostate Cancer Diagnostics Price Market Share by Type (2015-2020)
4.4 Global Prostate Cancer Diagnostics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Prostate Cancer Diagnostics Historic Market Analysis by Application
5.1 Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
5.2 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2015-2020)
5.3 Global Prostate Cancer Diagnostics Price by Application (2015-2020)

6 Company Profiles and Key Figures in Prostate Cancer Diagnostics Business
6.1 Genomic Health
6.1.1 Corporation Information
6.1.2 Genomic Health Description, Business Overview and Total Revenue
6.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Genomic Health Products Offered
6.1.5 Genomic Health Recent Development
6.2 Abbott
6.2.1 Abbott Prostate Cancer Diagnostics Production Sites and Area Served
6.2.2 Abbott Description, Business Overview and Total Revenue
6.2.3 Abbott Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Abbott Products Offered
6.2.5 Abbott Recent Development
6.3 OPKO
6.3.1 OPKO Prostate Cancer Diagnostics Production Sites and Area Served
6.3.2 OPKO Description, Business Overview and Total Revenue
6.3.3 OPKO Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.3.4 OPKO Products Offered
6.3.5 OPKO Recent Development
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Prostate Cancer Diagnostics Production Sites and Area Served
6.4.2 Siemens Healthcare Description, Business Overview and Total Revenue
6.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Siemens Healthcare Products Offered
6.4.5 Siemens Healthcare Recent Development
6.5 DiaSorin
6.5.1 DiaSorin Prostate Cancer Diagnostics Production Sites and Area Served
6.5.2 DiaSorin Description, Business Overview and Total Revenue
6.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.5.4 DiaSorin Products Offered
6.5.5 DiaSorin Recent Development
6.6 BioMeriux
6.6.1 BioMeriux Prostate Cancer Diagnostics Production Sites and Area Served
6.6.2 BioMeriux Description, Business Overview and Total Revenue
6.6.3 BioMeriux Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.6.4 BioMeriux Products Offered
6.6.5 BioMeriux Recent Development
6.7 Roche
6.6.1 Roche Prostate Cancer Diagnostics Production Sites and Area Served
6.6.2 Roche Description, Business Overview and Total Revenue
6.6.3 Roche Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Roche Products Offered
6.7.5 Roche Recent Development
6.8 MDx Health
6.8.1 MDx Health Prostate Cancer Diagnostics Production Sites and Area Served
6.8.2 MDx Health Description, Business Overview and Total Revenue
6.8.3 MDx Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.8.4 MDx Health Products Offered
6.8.5 MDx Health Recent Development
6.9 Beckman Coulter
6.9.1 Beckman Coulter Prostate Cancer Diagnostics Production Sites and Area Served
6.9.2 Beckman Coulter Description, Business Overview and Total Revenue
6.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Beckman Coulter Products Offered
6.9.5 Beckman Coulter Recent Development
6.10 Myriad Genetics
6.10.1 Myriad Genetics Prostate Cancer Diagnostics Production Sites and Area Served
6.10.2 Myriad Genetics Description, Business Overview and Total Revenue
6.10.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Myriad Genetics Products Offered
6.10.5 Myriad Genetics Recent Development
6.11 Ambry Genetics
6.11.1 Ambry Genetics Prostate Cancer Diagnostics Production Sites and Area Served
6.11.2 Ambry Genetics Prostate Cancer Diagnostics Description, Business Overview and Total Revenue
6.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Ambry Genetics Products Offered
6.11.5 Ambry Genetics Recent Development

7 Prostate Cancer Diagnostics Manufacturing Cost Analysis
7.1 Prostate Cancer Diagnostics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prostate Cancer Diagnostics
7.4 Prostate Cancer Diagnostics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prostate Cancer Diagnostics Distributors List
8.3 Prostate Cancer Diagnostics Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Prostate Cancer Diagnostics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prostate Cancer Diagnostics by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Prostate Cancer Diagnostics by Type (2021-2026)
10.2 Prostate Cancer Diagnostics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prostate Cancer Diagnostics by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Prostate Cancer Diagnostics by Application (2021-2026)
10.3 Prostate Cancer Diagnostics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prostate Cancer Diagnostics by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Prostate Cancer Diagnostics by Region (2021-2026)
10.4 North America Prostate Cancer Diagnostics Estimates and Projections (2021-2026)
10.5 Europe Prostate Cancer Diagnostics Estimates and Projections (2021-2026)
10.6 Asia Pacific Prostate Cancer Diagnostics Estimates and Projections (2021-2026)
10.7 Latin America Prostate Cancer Diagnostics Estimates and Projections (2021-2026)
10.8 Middle East and Africa Prostate Cancer Diagnostics Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Prostate Cancer Diagnostics Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Prostate Cancer Diagnostics Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Prostate Cancer Diagnostics Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Prostate Cancer Diagnostics Manufacturers Covered in This Study
Table 5. Global Prostate Cancer Diagnostics Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Prostate Cancer Diagnostics Sales Share by Manufacturers (2015-2020)
Table 7. Global Prostate Cancer Diagnostics Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Prostate Cancer Diagnostics Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Prostate Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Prostate Cancer Diagnostics Sales Sites and Area Served
Table 11. Manufacturers Prostate Cancer Diagnostics Product Types
Table 12. Global Prostate Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prostate Cancer Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnostics as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Prostate Cancer Diagnostics Players
Table 16. Global Prostate Cancer Diagnostics Sales (K Units) by Region (2015-2020)
Table 17. Global Prostate Cancer Diagnostics Sales Market Share by Region (2015-2020)
Table 18. Global Prostate Cancer Diagnostics Revenue (Million US$) by Region (2015-2020)
Table 19. Global Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2020)
Table 20. North America Prostate Cancer Diagnostics Sales by Country (2015-2020) (K Units)
Table 21. North America Prostate Cancer Diagnostics Sales Market Share by Country (2015-2020)
Table 22. North America Prostate Cancer Diagnostics Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Prostate Cancer Diagnostics Revenue Market Share by Country (2015-2020)
Table 24. Europe Prostate Cancer Diagnostics Sales by Country (2015-2020) (K Units)
Table 25. Europe Prostate Cancer Diagnostics Sales Market Share by Country (2015-2020)
Table 26. Europe Prostate Cancer Diagnostics Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Prostate Cancer Diagnostics Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Prostate Cancer Diagnostics Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Prostate Cancer Diagnostics Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Prostate Cancer Diagnostics Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2020)
Table 32. Latin America Prostate Cancer Diagnostics Sales by Country (2015-2020) (K Units)
Table 33. Latin America Prostate Cancer Diagnostics Sales Market Share by Country (2015-2020)
Table 34. Latin America Prostate Cancer Diagnostics Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Prostate Cancer Diagnostics Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Prostate Cancer Diagnostics Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Prostate Cancer Diagnostics Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Prostate Cancer Diagnostics Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Prostate Cancer Diagnostics Revenue Market Share by Country (2015-2020)
Table 40. Global Prostate Cancer Diagnostics Sales (K Units) by Type (2015-2020)
Table 41. Global Prostate Cancer Diagnostics Sales Share by Type (2015-2020)
Table 42. Global Prostate Cancer Diagnostics Revenue (Million US$) by Type (2015-2020)
Table 43. Global Prostate Cancer Diagnostics Revenue Share by Type (2015-2020)
Table 44. Global Prostate Cancer Diagnostics Price (USD/Unit) by Type (2015-2020)
Table 45. Global Prostate Cancer Diagnostics Sales (K Units) by Application (2015-2020)
Table 46. Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Table 47. Global Prostate Cancer Diagnostics Sales Growth Rate by Application (2015-2020)
Table 48. Genomic Health Prostate Cancer Diagnostics Corporation Information
Table 49. Genomic Health Description and Business Overview
Table 50. Genomic Health Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Genomic Health Main Product
Table 52. Genomic Health Recent Development
Table 53. Abbott Prostate Cancer Diagnostics Corporation Information
Table 54. Abbott Corporation Information
Table 55. Abbott Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Abbott Main Product
Table 57. Abbott Recent Development
Table 58. OPKO Prostate Cancer Diagnostics Corporation Information
Table 59. OPKO Corporation Information
Table 60. OPKO Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. OPKO Main Product
Table 62. OPKO Recent Development
Table 63. Siemens Healthcare Prostate Cancer Diagnostics Corporation Information
Table 64. Siemens Healthcare Corporation Information
Table 65. Siemens Healthcare Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Siemens Healthcare Main Product
Table 67. Siemens Healthcare Recent Development
Table 68. DiaSorin Prostate Cancer Diagnostics Corporation Information
Table 69. DiaSorin Corporation Information
Table 70. DiaSorin Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. DiaSorin Main Product
Table 72. DiaSorin Recent Development
Table 73. BioMeriux Prostate Cancer Diagnostics Corporation Information
Table 74. BioMeriux Corporation Information
Table 75. BioMeriux Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. BioMeriux Main Product
Table 77. BioMeriux Recent Development
Table 78. Roche Prostate Cancer Diagnostics Corporation Information
Table 79. Roche Corporation Information
Table 80. Roche Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Roche Main Product
Table 82. Roche Recent Development
Table 83. MDx Health Prostate Cancer Diagnostics Corporation Information
Table 84. MDx Health Corporation Information
Table 85. MDx Health Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. MDx Health Main Product
Table 87. MDx Health Recent Development
Table 88. Beckman Coulter Prostate Cancer Diagnostics Corporation Information
Table 89. Beckman Coulter Corporation Information
Table 90. Beckman Coulter Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Beckman Coulter Main Product
Table 92. Beckman Coulter Recent Development
Table 93. Myriad Genetics Prostate Cancer Diagnostics Corporation Information
Table 94. Myriad Genetics Corporation Information
Table 95. Myriad Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Myriad Genetics Main Product
Table 97. Myriad Genetics Recent Development
Table 98. Ambry Genetics Prostate Cancer Diagnostics Corporation Information
Table 99. Ambry Genetics Corporation Information
Table 100. Ambry Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Ambry Genetics Main Product
Table 102. Ambry Genetics Recent Development
Table 103. Sales Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Prostate Cancer Diagnostics Distributors List
Table 106. Prostate Cancer Diagnostics Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global Prostate Cancer Diagnostics Sales (K Units) Forecast by Type (2021-2026)
Table 111. Global Prostate Cancer Diagnostics Sales Market Share Forecast by Type (2021-2026)
Table 112. Global Prostate Cancer Diagnostics Revenue (Million US$) Forecast by Type (2021-2026)
Table 113. Global Prostate Cancer Diagnostics Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 114. Global Prostate Cancer Diagnostics Sales (K Units) Forecast by Application (2021-2026)
Table 115. Global Prostate Cancer Diagnostics Revenue (Million US$) Forecast by Application (2021-2026)
Table 116. Global Prostate Cancer Diagnostics Sales (K Units) Forecast by Region (2021-2026)
Table 117. Global Prostate Cancer Diagnostics Sales Market Share Forecast by Region (2021-2026)
Table 118. Global Prostate Cancer Diagnostics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Global Prostate Cancer Diagnostics Revenue Market Share Forecast by Region (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Prostate Cancer Diagnostics
Figure 2. Global Prostate Cancer Diagnostics Sales Market Share by Type: 2020 VS 2026
Figure 3. Tumor Biomarker Tests Product Picture
Figure 4. Imaging Product Picture
Figure 5. Biopsy Product Picture
Figure 6. Other Product Picture
Figure 7. Global Prostate Cancer Diagnostics Consumption Market Share by Application: 2020 VS 2026
Figure 8. age < 55
Figure 9. age 55-75
Figure 10. age > 75
Figure 11. Global Prostate Cancer Diagnostics Market Size 2015-2026 (US$ Million)
Figure 12. Global Prostate Cancer Diagnostics Sales Capacity (K Units) (2015-2026)
Figure 13. Global Prostate Cancer Diagnostics Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Prostate Cancer Diagnostics Sales Share by Manufacturers in 2020
Figure 15. Global Prostate Cancer Diagnostics Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Prostate Cancer Diagnostics Revenue in 2019
Figure 17. Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Prostate Cancer Diagnostics Sales Market Share by Region (2015-2020)
Figure 19. Global Prostate Cancer Diagnostics Sales Market Share by Region in 2019
Figure 20. Global Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2020)
Figure 21. Global Prostate Cancer Diagnostics Revenue Market Share by Region in 2019
Figure 22. North America Prostate Cancer Diagnostics Sales Market Share by Country in 2019
Figure 23. North America Prostate Cancer Diagnostics Revenue Market Share by Country in 2019
Figure 24. U.S. Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 25. U.S. Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Prostate Cancer Diagnostics Sales Market Share by Country in 2019
Figure 29. Europe Prostate Cancer Diagnostics Revenue Market Share by Country in 2019
Figure 30. Germany Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 31. Germany Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 37. Italy Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 39. Russia Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Prostate Cancer Diagnostics Sales Market Share by Region in 2019
Figure 41. Asia Pacific Prostate Cancer Diagnostics Revenue Market Share by Region in 2019
Figure 42. China Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 43. China Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 45. Japan Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 49. India Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 51. Australia Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 57. Thailand Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 59. Malaysia Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 61. Philippines Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 63. Vietnam Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Prostate Cancer Diagnostics Sales Market Share by Country in 2019
Figure 65. Latin America Prostate Cancer Diagnostics Revenue Market Share by Country in 2019
Figure 66. Mexico Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 67. Mexico Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 69. Brazil Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Prostate Cancer Diagnostics Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Prostate Cancer Diagnostics Revenue Market Share by Country in 2019
Figure 74. Turkey Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 75. Turkey Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 77. Saudi Arabia Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Prostate Cancer Diagnostics Sales Growth Rate (2015-2020) (K Units)
Figure 79. U.A.E Prostate Cancer Diagnostics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Prostate Cancer Diagnostics by Type (2015-2020)
Figure 81. Sales Market Share of Prostate Cancer Diagnostics by Type in 2019
Figure 82. Revenue Share of Prostate Cancer Diagnostics by Type (2015-2020)
Figure 83. Revenue Market Share of Prostate Cancer Diagnostics by Type in 2019
Figure 84. Global Prostate Cancer Diagnostics Sales Growth by Type (2015-2020) (K Units)
Figure 85. Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2020)
Figure 86. Global Prostate Cancer Diagnostics Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Prostate Cancer Diagnostics by Application (2015-2020)
Figure 88. Global Revenue Share of Prostate Cancer Diagnostics by Application in 2020
Figure 89. Genomic Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. OPKO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. DiaSorin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. BioMeriux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. MDx Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Myriad Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Ambry Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Price Trend of Key Raw Materials
Figure 101. Manufacturing Cost Structure of Prostate Cancer Diagnostics
Figure 102. Manufacturing Process Analysis of Prostate Cancer Diagnostics
Figure 103. Prostate Cancer Diagnostics Industrial Chain Analysis
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. North America Prostate Cancer Diagnostics Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. North America Prostate Cancer Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Prostate Cancer Diagnostics Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Prostate Cancer Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Prostate Cancer Diagnostics Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Prostate Cancer Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Prostate Cancer Diagnostics Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Prostate Cancer Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Prostate Cancer Diagnostics Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Prostate Cancer Diagnostics Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Bottom-up and Top-down Approaches for This Report
Figure 118. Data Triangulation
Figure 119. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $4350
USD $5800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.